Improved PFS in Advanced Kidney Cancer With Antiangiogenic Combination

By News Health
3 months Ago

(MedPage Today) — SAN FRANCISCO — Dual antiangiogenic therapy for previously treated kidney cancer significantly improved progression-free survival (PFS) versus a single drug, a large randomized trial showed.
Median PFS improved from 10.7…

Source link : https://www.medpagetoday.com/meetingcoverage/ascogu/120094

Author :

Publish date : 2026-02-28 15:00:00

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Coal Mining and Cancer; Cancer Viruses in Wastewater; Sunscreens Miss the Mark Again

Datopotamab Deruxtecan Earns New Breast Cancer Indication

EMA OKs New Option for Pulmonary Fibrosis

Microvascular Dysfunction an Important Independent Contributor to Heart Disease

Ebola risk raised to 'very high' in DR Congo

What I Learned When We Treated a Possible Ebola Patient